- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04216264
Pattern - Reach Aim 2
21. oktober 2022 opdateret af: Duke University
Pilot Adaptive Tool To Encourage Risk Reduction in iNfancy (PATTERN)
The purpose of this research study is to learn about different approaches to promoting healthy growth among infants, and understanding parents' likes and dislikes of an approach to reducing risk factors for obesity later in life.
The study includes filling out some forms with questions about your baby and your thoughts about your baby's growth and health, and engaging in a pattern of changes in or prevention of risk factors in the first year of life.
Parents will receive information about changes and some tools and materials to take home with them.
Some parents may receive phone calls between visits as well.
The study takes place from soon after birth through the infant's age of 9 months.
The estimated total time of interaction between the study staff and parents during the study period is 4 hours.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
As this is a dyad study, each dyad is considered to be a participant and demographic information will reflect the infant in the dyad, per parent report.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
28
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27705
- Duke University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
2 uger til 2 måneder (Barn)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Non-Hispanic black (as documented in MaestroCare) parents/caregivers with; infants ages 2 weeks to 2 months of age; infant birthweight between 2500g and 4000g; infant gestational age is at least 36 weeks
Exclusion Criteria:
- non-English-speaking; infant with serious disease or disorder affecting growth and nutrition
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Ikke-randomiseret
- Interventionel model: Sekventiel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Response
|
Parents pick from a menu of behavior changes
|
|
Andet: Non-response
|
Stepped up phone interaction with parents based on menu of behavior changes
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Participants Satisfied or Very Satisfied With Information Given to Them, as Measured by Follow up Questionnaire
Tidsramme: 3 to 6 months after baseline assessment
|
Completed Likert scale with 1=very unsatisfied, 2=unsatisfied, 3=neutral, 4=satisfied, 5=very satisfied
|
3 to 6 months after baseline assessment
|
|
Percentage of Successful Contacts With Families Via Telephone and/or in Clinic
Tidsramme: 3 to 6 months after baseline assessment
|
Number of successful contacts with families divided by number of attempts to contact by research staff x 100
|
3 to 6 months after baseline assessment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Percent of Participants Exclusively Breastfeeding at 4 Months Postnatal Age
Tidsramme: 3 to 6 months after baseline assessment
|
Dyad caregivers were asked what type of milk was being consumed by the infant, with 4 options available: 1) Formula only, 2) Mostly formula and some breast milk, 3) Mostly breast milk, but some formula, or 4) Breast milk only.
|
3 to 6 months after baseline assessment
|
|
Percent of Participants Delaying Complementary Feeding Until 4 Months Postnatal Age
Tidsramme: 3 to 6 months after baseline assessment
|
Dyads caregivers were asked, "Is your baby eating solid foods yet or do you put any solid foods in the bottle?", with 2 options available: 1) Yes or 2) No
|
3 to 6 months after baseline assessment
|
|
Percent of Participants Reporting "Never" Engaging in Screentime While Feeding and With '0' Minutes of Active TV Watching at 4 Months Postnatal Age
Tidsramme: 3 to 6 months after baseline assessment
|
Dyad caregivers were asked "I watch TV or look at or use my phone while feeding my baby" and responded with one of 5 Likert-scale responses: 1) Never, 2) Seldom, 3) Half of the time, 4) Most of the time, 5) Always
|
3 to 6 months after baseline assessment
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Charles Wood, Duke University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
7. maj 2020
Primær færdiggørelse (Faktiske)
4. maj 2021
Studieafslutning (Faktiske)
4. maj 2021
Datoer for studieregistrering
Først indsendt
30. december 2019
Først indsendt, der opfyldte QC-kriterier
30. december 2019
Først opslået (Faktiske)
2. januar 2020
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
16. november 2022
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
21. oktober 2022
Sidst verificeret
1. oktober 2022
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- Pro00102738
- U54MD012530 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Standard response
-
Kansas State UniversityUnited Sorghum Checkoff ProgramAfsluttetBlodsukker
-
Cambridge University Hospitals NHS Foundation TrustMedical Research Council; National Institute for Health Research, United...RekrutteringGauchers sygdom, type III | Gauchers sygdom, type IDet Forenede Kongerige
-
Centre Hospitalier Universitaire Saint PierreUniversité Libre de BruxellesAfsluttetHypoxi | Hyperkapni | HyperventilationssyndromBelgien
-
University of PittsburghPatient-Centered Outcomes Research InstituteAfsluttetLungebetændelse | Sepsis | Covid19 | Infektion i nedre respForenede Stater
-
GE HealthcareAfsluttetKirurgisk procedure, uspecificeretFinland, Holland, Tyskland, Ungarn
-
Fondation Ophtalmologique Adolphe de RothschildAfsluttet
-
Centre Hospitalier Universitaire de NīmesAfsluttetCarotis endarterektomiFrankrig
-
University of JaénAfsluttetDyrke motion | AldringColombia
-
Beth Israel Deaconess Medical CenterCenters for Disease Control and PreventionAfsluttet
-
Dominik StraumannUniversity Hospital, Zürich; BrainCare Medical GroupRekrutteringSvimmelhed | Traumatisk hjerneskade | Hjernerystelse (diagnose) | BalancevurderingSchweiz